Systematic reviews of Artificial Intelligence (AI)

A series of projects examining the ethics and validity of the use of AI in clinical trials and its impact on clinical translation using systematic review methods.

• Impact and outcomes for drugs and biologicals that have been repurposed as therapy for Covid-19 on the basis of artificial intelligence or machine learning hypotheses
• Artificial intelligence for clinical decision support in acute ischemic stroke care

In close cooperation with: Benjamin Gregory Carlisle - McGill Department of Equity, Ethics and Policy Montréal, Québec, Canada, Research Associate